Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope.
Oncoimmunology
; 5(10): e1216290, 2016.
Article
en En
| MEDLINE
| ID: mdl-27853637
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2016
Tipo del documento:
Article